Cognitive Dysfunction in Major Depressive Disorder: Cause and Effect
- 141 Downloads
Purpose of Review
Major depressive disorder (MDD) is a pervasive and debilitating mental illness, associated with significant emotional, social, and functional deficits. Growing evidence suggests that cognitive dysfunction is a core feature of MDD and may negatively interact with other clinical features of the illness (e.g., psychosocial dysfunction, illness onset). We review recent advances in our understanding of cognitive dysfunction in MDD and highlight the putative causes and effects of cognitive deficits in depressed patients.
Recent findings in this domain point to a multifaceted pathology of cognitive deficits in MDD, with behavioural disengagement and chronic low-grade inflammation likely playing an antecedent role. Emerging evidence suggests an independent role for cognitive deficits in the development of psychosocial dysfunction, particularly in domains of occupational function, interpersonal relationships, and quality of life.
While the pathology of cognitive deficits in MDD is complex and multifaceted, recent advances provide clarity in select areas. Executive functioning stands out as a cognitive domain crucial to adaptive psychosocial status, highlighting the importance of remediating executive deficits with cognitive treatment. Low-grade inflammation may indicate a predisposition to severe, treatment-resistant depression and associated cognitive deficits. Screening for specific cognitive deficits and inflammatory markers in depressed patients may therefore prove crucial in the advancement of our detection and treatment of major depression.
KeywordsMajor depression MDD Cognitive dysfunction Inflammation Executive function Psychosocial functioning
Compliance with Ethical Standards
Conflict of Interest
BB received speaker/consultation fees from AstraZeneca, Lundbeck, Pfizer, Takeda, Servier, Bristol Myers Squibb, Otsuka, and Janssen-Cilag. The remaining authors have no conflicts of interest to declare.
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.World Health Organisation. Depression and other common mental disorders. World Health Organisation, http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf. 2017. http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf. Accessed January, 2018 2018.
- 5.Bortolato B, F Carvalho A, S McIntyre R. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2014;13(10):1804–18.Google Scholar
- 6.•• Cambridge OR, Knight MJ, Mills N, Baune BT. The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: a systematic review. Psychiatry Res. 2018;269:157–71. A comprehensive review of clinical research that supports a broad relationship between cognitive and psychosocial dysfunction in MDD. Longitudinal and cross-sectional data are reported separately, highlighting recent advances and future directions for cognitive research in MDD. CrossRefGoogle Scholar
- 10.McIntyre RS, Soczynska JZ, Woldeyohannes HO, Alsuwaidan MT, Cha DS, Carvalho AF, et al. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Compr Psychiatry. 2015;56:279–82. https://doi.org/10.1016/j.comppsych.2014.08.051.CrossRefPubMedGoogle Scholar
- 11.Robinson OJ, Roiser JP, Sahakian BJ. Hot and cold cognition in major depressive disorder. Cognitive Impairment in Major Depressive Disorder: Clinical Relevance Biol Substrates, and Treatment Opportunities 2016:69.Google Scholar
- 13.American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®), (5th ed.). Washington, DC; 2013.Google Scholar
- 15.• McIntyre RS, Best MW, Bowie CR, Carmona NE, Cha DS, Lee Y, et al. The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J Clin Psychiatry. 2017;78(7):873–81. https://doi.org/10.4088/JCP.16m11329. The authors examine the validity of the THINC-integrated tool for detecting cognitive impairment in MDD patients. The results support the THINC-it tool as a brief and valid instrument which for detecting cognitive deficits in MDD patients relative to healthy controls. CrossRefPubMedGoogle Scholar
- 31.Langenecker SA, Dawson EL, Mickey BJ, Ransom MT, Walker SJ, Meyers KK et al., editors. Cognitive control and neuronal functioning biomarkers as predictors of treatment response in major depression. Biological Psychiatry; 2014: Elsevier Science Inc 360 Park Ave South, New York, NY 10010–1710 USA.Google Scholar
- 44.Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ, et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry. 2005;57(3):201–9. https://doi.org/10.1016/j.biopsych.2004.10.028.CrossRefPubMedGoogle Scholar
- 45.Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry. 2007;61(2):198–209. https://doi.org/10.1016/j.biopsych.2006.05.048.CrossRefPubMedGoogle Scholar
- 46.Fales CL, Barch DM, Rundle MM, Mintun MA, Mathews J, Snyder AZ, et al. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. J Affect Disord. 2009;112(1–3):206–11. https://doi.org/10.1016/j.jad.2008.04.027.CrossRefPubMedGoogle Scholar
- 47.Fu CY, Williams SR, Cleare AJ, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry. 2004;61(9):877–89. https://doi.org/10.1001/archpsyc.61.9.877.CrossRefPubMedGoogle Scholar
- 49.Schaefer HS, Putnam KM, Benca RM, Davidson RJ. Event-related functional magnetic resonance imaging measures of neural activity to positive social stimuli in pre- and post-treatment depression. Biol Psychiatry. 2006;60(9):974–86. https://doi.org/10.1016/j.biopsych.2006.03.024.CrossRefPubMedGoogle Scholar
- 50.Fourrier C, Sampson E, Mills NT, Baune BT. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Trials. 2018;In Press.Google Scholar
- 51.Dowell NG, Cooper EA, Tibble J, Voon V, Critchley HD, Cercignani M, et al. Acute changes in striatal microstructure predict the development of interferon-alpha induced fatigue. Biol Psychiatry. 2016;79(4):320–8. https://doi.org/10.1016/j.biopsych.2015.05.015.CrossRefPubMedPubMedCentralGoogle Scholar
- 52.• Harrison JE, Lophaven S, Olsen CK. Which cognitive domains are improved by treatment with vortioxetine? Int J Neuropsychopharmacol. 2016;19(10):pyw054-pyw. https://doi.org/10.1093/ijnp/pyw054. A follow-up analysis using data from a large scale RCT that reports the effectiveness of Vortioxetine in improving general cognitive performance in individuals with MDD. This study adds evidence to the hypothesis that cognitive dysfunction and depressive symptoms should be treated concurrently. CrossRefGoogle Scholar
- 54.Rosenblat JD, Brietzke E, Mansur RB, Maruschak NA, Lee Y, McIntyre RS. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J Affect Disord. 2015;188:149–59. https://doi.org/10.1016/J.Jad.2015.08.058.CrossRefPubMedGoogle Scholar
- 61.Harrison NA. Brain structures implicated in inflammation-associated depression. Inflammation-Associated Depression: Evidence, Mechanisms and Implications. Springer; 2016. p. 221–48.Google Scholar
- 72.McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30(6):515–27. https://doi.org/10.1002/da.22063.CrossRefPubMedGoogle Scholar
- 79.Caldirola D, Grassi M, Riva A, Daccò S, De Berardis D, Dal Santo B, et al. Self-reported quality of life and clinician-rated functioning in mood and anxiety disorders: relationships and neuropsychological correlates. Compr Psychiatry. 2014;55(4):979–88. https://doi.org/10.1016/j.comppsych.2013.12.007.CrossRefPubMedGoogle Scholar
- 83.Harvey PD, Penn D. Social cognition: the key factor predicting social outcome in people with schizophrenia? Psychiatry (Edgmont). 2010;7(2):41–4.Google Scholar
- 84.Knight MJ, Baune BT. Social cognitive abilities predict psychosocial dysfunction in major depressive disorder. Depression Anxiety 2018:1–9. https://doi.org/10.1002/da.22844.
- 91.Demeyer I, De Lissnyder E, Koster EH, De Raedt R. Rumination mediates the relationship between impaired cognitive control for emotional information and depressive symptoms: a prospective study in remitted depressed adults. Behav Res Ther. 2012;50(5):292–7. https://doi.org/10.1016/j.brat.2012.02.012.CrossRefPubMedGoogle Scholar
- 101.Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D, McCulloch C, et al. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68(1):33–41. https://doi.org/10.1001/archgenpsychiatry.2010.177.CrossRefPubMedPubMedCentralGoogle Scholar